← Browse by Condition
Medical Condition

lv dysfunction

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06705023 Phase 2
Recruiting

Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.

Enrollment
36 pts
Location
Kazakhstan
Sponsor
Ralf Rothoerl
View Trial →